Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Anticoagulation Dosing and Adherence for Patients With Non-valvular Atrial Fibrillation

NCT03719144 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03719144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03719144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Anticoagulation Dosing and Adherence for Patients With Non-valvular Atrial Fibrillation
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
April 8, 2019
Completion date
March 24, 2020
Enrollment
581 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation